AU6584801A - Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine - Google Patents

Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine

Info

Publication number
AU6584801A
AU6584801A AU6584801A AU6584801A AU6584801A AU 6584801 A AU6584801 A AU 6584801A AU 6584801 A AU6584801 A AU 6584801A AU 6584801 A AU6584801 A AU 6584801A AU 6584801 A AU6584801 A AU 6584801A
Authority
AU
Australia
Prior art keywords
adenosyl
methionine
preparation
pharmaceutically acceptable
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU6584801A
Other languages
English (en)
Inventor
Marco Berna
Lino Sivieri
Gianni Santambrogio
Ermanno Valoti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chementecno Srl
Original Assignee
Chementecno Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chementecno Srl filed Critical Chementecno Srl
Publication of AU6584801A publication Critical patent/AU6584801A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU6584801A 2000-05-25 2001-03-30 Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine Pending AU6584801A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001158A IT1318535B1 (it) 2000-05-25 2000-05-25 Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina.
PCT/EP2001/003633 WO2001090130A1 (en) 2000-05-25 2001-03-30 Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine

Publications (1)

Publication Number Publication Date
AU6584801A true AU6584801A (en) 2001-12-03

Family

ID=11445118

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6584801A Pending AU6584801A (en) 2000-05-25 2001-03-30 Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
AU2001265848A Expired AU2001265848B8 (en) 2000-05-25 2001-03-30 Process for the preparation of pharmaceutically acceptable salts of (SS,RS)-S-adenosyl-L-methionine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001265848A Expired AU2001265848B8 (en) 2000-05-25 2001-03-30 Process for the preparation of pharmaceutically acceptable salts of (SS,RS)-S-adenosyl-L-methionine

Country Status (14)

Country Link
US (2) US20020010147A1 (enExample)
EP (1) EP1283845B1 (enExample)
JP (1) JP4777588B2 (enExample)
KR (1) KR100737193B1 (enExample)
AT (1) ATE256695T1 (enExample)
AU (2) AU6584801A (enExample)
CA (1) CA2407559C (enExample)
DE (1) DE60101575T2 (enExample)
DK (1) DK1283845T3 (enExample)
ES (1) ES2208610T3 (enExample)
IT (1) IT1318535B1 (enExample)
PT (1) PT1283845E (enExample)
TR (1) TR200302297T4 (enExample)
WO (1) WO2001090130A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033815B2 (en) 2001-03-30 2006-04-25 Board Of Regents, The University Of Texas System Biosynthesis of S-adenosylmethionine in a recombinant yeast strain
CN100398659C (zh) * 2002-09-16 2008-07-02 上海青瑞生物医药技术有限公司 旋光纯(s,s)-腺甘甲硫氨酸制备的方法
US20050272687A1 (en) * 2004-06-08 2005-12-08 Hebert Rolland F Stable S-adenosyl-l-methionine
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ES2406412T3 (es) * 2005-06-09 2013-06-06 Gnosis S.P.A. Células de Saccharomyces cerevisiae secas, liofilizadas y/o microencapsuladas con un alto contenido de (S)-(+)-S-adenosil-metionina
ITRM20050344A1 (it) * 2005-06-30 2007-01-01 Luca Maria De Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
CN1955306B (zh) * 2005-10-28 2011-03-16 上海医药工业研究院 酵母菌生物合成、生产旋光纯腺苷甲硫氨酸的方法及其培养液
ITMI20060629A1 (it) 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
KR101070494B1 (ko) 2006-05-10 2011-10-05 미쓰비시 타나베 파마 코퍼레이션 Ｓ-아데노실-ｌ-메티오닌 함유 건조 효모의 제조방법 및 경구 섭취용 조성물
US20070265211A1 (en) * 2006-05-12 2007-11-15 Matthias Rath Novel composition and method effective in inhibiting the atherogenic process
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
JP6479681B2 (ja) 2013-01-16 2019-03-06 ヘーベルト サム−イー エルエルシー Ｓ−アデノシル−ｌ−メチオニンの安定なインドール−３−プロピオネート塩
ITMI20130426A1 (it) * 2013-03-20 2014-09-21 Gnosis Spa S-adenosilmetionina sterile ad alto contenuto di isomero attivo per soluzioni iniettabili e procedimento per ottenerla
CN106349311B (zh) * 2016-08-23 2018-04-13 北京金阳利康医药有限公司 从酵母发酵液中提取s‑腺苷蛋氨酸的方法
IT201700074957A1 (it) 2017-07-04 2019-01-04 Gnosis Spa Sale di (ss)-adenosil metionina con inositolo esafosfato e procedimento per ottenerlo
CN110396120B (zh) * 2019-02-13 2020-05-12 山东惠仕莱生物科技有限公司 一种从s-腺苷蛋氨酸发酵液中提取分离s-腺苷蛋氨酸的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
JPS56145299A (en) * 1980-04-11 1981-11-11 Kanegafuchi Chem Ind Co Ltd Purification of s-adenosyl-l-methionine
JPS5929700A (ja) * 1982-08-13 1984-02-16 Nippon Zeon Co Ltd Ｓ−アデノシル−ｌ−メチオニンの精製法
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale

Also Published As

Publication number Publication date
CA2407559C (en) 2009-12-22
AU2001265848B8 (en) 2006-05-04
US6958233B2 (en) 2005-10-25
PT1283845E (pt) 2004-04-30
EP1283845A1 (en) 2003-02-19
KR20030036183A (ko) 2003-05-09
ITMI20001158A0 (it) 2000-05-25
ITMI20001158A1 (it) 2001-11-25
TR200302297T4 (tr) 2004-02-23
DE60101575T2 (de) 2004-06-03
US20020173012A1 (en) 2002-11-21
ATE256695T1 (de) 2004-01-15
AU2001265848B2 (en) 2006-03-23
JP4777588B2 (ja) 2011-09-21
IT1318535B1 (it) 2003-08-27
DK1283845T3 (da) 2004-04-13
KR100737193B1 (ko) 2007-07-10
EP1283845B1 (en) 2003-12-17
DE60101575D1 (de) 2004-01-29
WO2001090130A1 (en) 2001-11-29
CA2407559A1 (en) 2001-11-29
US20020010147A1 (en) 2002-01-24
ES2208610T3 (es) 2004-06-16
JP2003534349A (ja) 2003-11-18

Similar Documents

Publication Publication Date Title
AU6584801A (en) Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
CA2412708A1 (en) Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
GEP20053476B (en) 3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents
DE60117289D1 (de) Schnelllösliche tabletten
GEP20104895B (en) Preparation of pregabalin and related compounds
BG103945A (en) Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a
MXPA02003203A (es) Composiciones terapeuticas solubles en tocol.
BG106013A (en) New compounds and compositions as protease inhibitors
AP2002002637A0 (en) Novel piperazine
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
BG106681A (en) Solutions containing epinastine
YU83502A (sh) Nova farmaceutska smeša
MXPA02006826A (es) Un inhibidor de division celular y un metodo de produccion del mismo.
MY115980A (en) Topical ketoconazole emulsions.
HK1052346A1 (zh) 有效用作β-2-肾上腺素受体激动剂以及PDE4-抑制剂的化合物
PL363081A1 (en) Growth hormone secretagogues
IN2012DE00109A (enExample)
MXPA02004701A (es) Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos.
BG108426A (en) Novel sulfonic acid derivatives
WO2002003974A3 (en) Composition comprising folic acid and zinc for improving male fertility
MY119090A (en) Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them
ES2058029A1 (es) Proceso para la produccion de sales del acido clavulanico.
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
EP1152762B8 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
AU2566101A (en) Compounds and methods for the treatment of pain